US › Healthcare

Volitionrx Ltd (VNRX)

US · Healthcare · Medical Devices

$0.79-1.81%

Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue

$985,076

Revenue YoY

+299.8%

Net profit

$-6.7M

Profit YoY

-22.9%

EPS

$-0.97

EPS estimate

$-0.73

Net margin

-676.6%

EPS came in at -0.97 against a street estimate of -0.73 — a miss of 32.9%.

Key statistics

Market cap

$8.6M

Forward P/E

20.8

P/B

38.44

Book value

$-4.03

EPS (TTM)

$-4.25

52-week high

$15.10

52-week low

$0.69

50-day MA

$1.55

200-day MA

$4.23

Beta

1.11

Analyst view

Analysts rate Volitionrx Ltd a buy (5 buy, 1 hold, 0 sell out of 6) with an average price target of $16.97.

Shareholding

Insiders

8.62%

Institutions

20.77%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Volitionrx Ltd — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc UnitedHealth Group Incorporated Merck & Company Inc Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Novo Nordisk A/S Amgen Inc Abbott Laboratories Gilead Sciences Inc

Data updated 2026-08-05.